Skip to main content
Top
Published in: Molecular Imaging and Biology 5/2017

01-10-2017 | Research Article

Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants

Authors: Jonathan S. Wall, Angela Williams, Tina Richey, Alan Stuckey, Craig Wooliver, J. Christopher Scott, Robert Donnell, Emily B. Martin, Stephen J. Kennel

Published in: Molecular Imaging and Biology | Issue 5/2017

Login to get access

Abstract

Purpose

The heparin-reactive, helical peptide p5 is an effective amyloid imaging agent in mice with systemic amyloidosis. Analogs of p5 with modified secondary structure characteristics exhibited altered binding to heparin, synthetic amyloid fibrils, and amyloid extracts in vitro. Herein, we further study the effects of peptide helicity and chirality on specific amyloid binding using a mouse model of systemic inflammation-associated (AA) amyloidosis.

Procedures

Peptides with disrupted helical structure [p5(coil) and p5(Pro3)], with an extended sheet conformation [p5(sheet)] or an all-D enantiomer [p5(D)], were chemically synthesized, radioiodinated, and their biodistribution studied in WT mice as well as transgenic animals with severe systemic AA amyloidosis. Peptide binding was assessed qualitatively by using small animal single-photon emission computed tomography/x-ray computed tomography imaging and microautoradiography and quantitatively using tissue counting.

Results

Peptides with reduced helical propensity, p5(coil) and p5(Pro3), exhibited significantly reduced binding to AA amyloid-laden organs. In contrast, peptide p5(D) was retained by non-amyloid-related ligands in the liver and kidneys of both WT and AA mice, but it also bound AA amyloid in the spleen. The p5(sheet) peptide specifically bound AA amyloid in vivo and was not retained by healthy tissues in WT animals.

Conclusions

Modification of amyloid-targeting peptides using D-amino acids should be performed cautiously due to the introduction of unexpected secondary pharmacologic effects. Peptides that adopt a helical structure, to align charged amino acid side chains along one face, exhibit specific reactivity with amyloid; however, polybasic peptides with a propensity for β-sheet conformation are also amyloid-reactive and may yield a novel class of amyloid-targeting agents for imaging and therapy.
Literature
1.
2.
go back to reference Lindahl B, Lindahl U (1997) Amyloid-specific heparan sulfate from human liver and spleen. J Biol Chem 272:26091–26094CrossRefPubMed Lindahl B, Lindahl U (1997) Amyloid-specific heparan sulfate from human liver and spleen. J Biol Chem 272:26091–26094CrossRefPubMed
3.
go back to reference Wall JS, Martin EB, Richey T et al (2015) Preclinical validation of the heparin-reactive peptide p5 + 14 as a molecular imaging agent for visceral amyloidosis. Molecules 20:7657–7682CrossRefPubMedPubMedCentral Wall JS, Martin EB, Richey T et al (2015) Preclinical validation of the heparin-reactive peptide p5 + 14 as a molecular imaging agent for visceral amyloidosis. Molecules 20:7657–7682CrossRefPubMedPubMedCentral
4.
go back to reference Smits NC, Kurup S, Rops AL et al (2010) The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. J Biol Chem 285:41143–41151CrossRefPubMedPubMedCentral Smits NC, Kurup S, Rops AL et al (2010) The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. J Biol Chem 285:41143–41151CrossRefPubMedPubMedCentral
5.
go back to reference Wall JS, Richey T, Stuckey A et al (2012) SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies. Nucl Med Biol 39:65–75CrossRefPubMed Wall JS, Richey T, Stuckey A et al (2012) SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies. Nucl Med Biol 39:65–75CrossRefPubMed
7.
go back to reference Wall JS, Richey T, Stuckey A, Donnell R, Macy S, Martin EB, Williams A, Higuchi K, Kennel SJ (2011) In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides. Proc Natl Acad Sci U S A 108:E586–E594CrossRefPubMedPubMedCentral Wall JS, Richey T, Stuckey A, Donnell R, Macy S, Martin EB, Williams A, Higuchi K, Kennel SJ (2011) In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides. Proc Natl Acad Sci U S A 108:E586–E594CrossRefPubMedPubMedCentral
8.
go back to reference Wall JS, Richey T, Williams A et al (2012) Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT. Mol Imaging Biol 14:402–407CrossRefPubMedPubMedCentral Wall JS, Richey T, Williams A et al (2012) Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT. Mol Imaging Biol 14:402–407CrossRefPubMedPubMedCentral
9.
go back to reference Wall JS, Williams A, Richey T et al (2013) A binding-site barrier affects imaging efficiency of high affinity amyloid-reactive peptide radiotracers in vivo. PLoS One 8:e66181CrossRefPubMedPubMedCentral Wall JS, Williams A, Richey T et al (2013) A binding-site barrier affects imaging efficiency of high affinity amyloid-reactive peptide radiotracers in vivo. PLoS One 8:e66181CrossRefPubMedPubMedCentral
10.
go back to reference Martin EB, Williams A, Heidel E et al (2013) Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts. Biochem Biophys Res Commun 436:85–89CrossRefPubMedPubMedCentral Martin EB, Williams A, Heidel E et al (2013) Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts. Biochem Biophys Res Commun 436:85–89CrossRefPubMedPubMedCentral
11.
go back to reference Jayaraman G, Wu CW, Liu YJ et al (2000) Binding of a de novo designed peptide to specific glycosaminoglycans. FEBS Lett 482:154–158CrossRefPubMed Jayaraman G, Wu CW, Liu YJ et al (2000) Binding of a de novo designed peptide to specific glycosaminoglycans. FEBS Lett 482:154–158CrossRefPubMed
12.
go back to reference Rullo A, Nitz M (2010) Importance of the spatial display of charged residues in heparin-peptide interactions. Biopolymers 93:290–298CrossRefPubMed Rullo A, Nitz M (2010) Importance of the spatial display of charged residues in heparin-peptide interactions. Biopolymers 93:290–298CrossRefPubMed
13.
go back to reference Wall J, Williams A, Wooliver C et al (2016) Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding—in vitro characterization. Biochem Biophys Rep 8:89–99PubMed Wall J, Williams A, Wooliver C et al (2016) Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding—in vitro characterization. Biochem Biophys Rep 8:89–99PubMed
14.
16.
go back to reference Munoz V, Serrano L (1997) Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. Biopolymers 41:495–509CrossRefPubMed Munoz V, Serrano L (1997) Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. Biopolymers 41:495–509CrossRefPubMed
18.
go back to reference Wall JS, Richey T, Allen A et al (2008) Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice. Comp Med 58:542–550PubMedPubMedCentral Wall JS, Richey T, Allen A et al (2008) Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice. Comp Med 58:542–550PubMedPubMedCentral
19.
go back to reference Magota K, Kubo N, Kuge Y et al (2011) Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging 38:742–752CrossRefPubMed Magota K, Kubo N, Kuge Y et al (2011) Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging 38:742–752CrossRefPubMed
20.
go back to reference Ogawa K (1994) Simulation study of triple-energy-window scatter correction in combined Tl-201, Tc-99 m SPECT. Ann Nucl Med 8:277–281CrossRefPubMed Ogawa K (1994) Simulation study of triple-energy-window scatter correction in combined Tl-201, Tc-99 m SPECT. Ann Nucl Med 8:277–281CrossRefPubMed
21.
go back to reference Feldkamp L, Davis L, Kress J (1984) Practical cone-beam algorithm. J Opt Soc Am 1:612–619CrossRef Feldkamp L, Davis L, Kress J (1984) Practical cone-beam algorithm. J Opt Soc Am 1:612–619CrossRef
22.
go back to reference Martin EB, Kennel SJ, Richey T et al (2014) Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation. Peptides 60:63–70CrossRefPubMedPubMedCentral Martin EB, Kennel SJ, Richey T et al (2014) Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation. Peptides 60:63–70CrossRefPubMedPubMedCentral
23.
25.
go back to reference Li C, Zhan C, Zhao L et al (2013) Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction. Bioorg Med Chem 21:4045–4050CrossRefPubMedPubMedCentral Li C, Zhan C, Zhao L et al (2013) Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction. Bioorg Med Chem 21:4045–4050CrossRefPubMedPubMedCentral
26.
go back to reference Araujo RL, Carvalho DP (2011) Bioenergetic impact of tissue-specific regulation of iodothyronine deiodinases during nutritional imbalance. J Bioenerg Biomembr 43:59–65CrossRefPubMed Araujo RL, Carvalho DP (2011) Bioenergetic impact of tissue-specific regulation of iodothyronine deiodinases during nutritional imbalance. J Bioenerg Biomembr 43:59–65CrossRefPubMed
27.
go back to reference Wall J, Martin E, Donnell R, Richey T, Stuckey A, Kennel SJ (2014) Heparin-binding peptides, basic fibroblast growth factor and p5R, bind to different targets in amyloid-laden mice and controls. In: Kluve-Beckerman B, Liepnieks J, Benson M (eds) The XIVth International Symposium on Amyloidosis, Indianapolis, IN, USA. Amyloid: Insoluble, but Solvable. pp 284–287 Wall J, Martin E, Donnell R, Richey T, Stuckey A, Kennel SJ (2014) Heparin-binding peptides, basic fibroblast growth factor and p5R, bind to different targets in amyloid-laden mice and controls. In: Kluve-Beckerman B, Liepnieks J, Benson M (eds) The XIVth International Symposium on Amyloidosis, Indianapolis, IN, USA. Amyloid: Insoluble, but Solvable. pp 284–287
Metadata
Title
Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants
Authors
Jonathan S. Wall
Angela Williams
Tina Richey
Alan Stuckey
Craig Wooliver
J. Christopher Scott
Robert Donnell
Emily B. Martin
Stephen J. Kennel
Publication date
01-10-2017
Publisher
Springer US
Published in
Molecular Imaging and Biology / Issue 5/2017
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-017-1063-0

Other articles of this Issue 5/2017

Molecular Imaging and Biology 5/2017 Go to the issue